Your session is about to expire
← Back to Search
Nerve Stimulator
Nerve Stimulation Wearable for Post-Concussion Syndrome
N/A
Recruiting
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention and after three and six weeks of device use
Awards & highlights
Study Summary
This trial tests the effect of a wearable nerve stimulator on teens with post-concussion symptoms. It'll measure symptom relief, cognitive improvement and recovery. Participants will wear it daily for 6 weeks.
Who is the study for?
This trial is for adolescents who have been diagnosed with a concussion and are experiencing ongoing symptoms. They should be able to follow simple instructions and sit upright for at least 30 minutes. Those with severe brain injuries, schizophrenia, bipolar disorder, epilepsy, cerebral palsy, or severe sensory disorders cannot participate.Check my eligibility
What is being tested?
The study is testing the Apollo Neuro device—a wearable nerve stimulator—on its ability to lessen symptoms and cognitive issues caused by concussions in adolescents. Participants will use the device daily over six weeks while their recovery progress is monitored through assessments.See study design
What are the potential side effects?
Potential side effects of using the Apollo Neuro device may include discomfort at the site of wear or skin irritation due to prolonged contact with the device material. However, specific side effects related to this nerve stimulation technology will be closely observed during the trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-intervention and after three and six weeks of device use
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention and after three and six weeks of device use
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in concussion symptoms from pre-injury levels
Changes in anxiety symptoms
Changes in balance
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Apollo Neuro GroupExperimental Treatment1 Intervention
The group will use the Apollo Neuro device daily for six weeks as an adjunct to their standard treatment plan.
Group II: Standard Treatment GroupActive Control1 Intervention
The group will follow their standard treatment plan.
Find a Location
Who is running the clinical trial?
Prisma Health-MidlandsOTHER
23 Previous Clinical Trials
2,726 Total Patients Enrolled
University of South CarolinaLead Sponsor
211 Previous Clinical Trials
120,359 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a concussion.I have had a moderate or severe brain injury in the past.I can sit upright for at least 30 minutes without needing a break.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Treatment Group
- Group 2: Apollo Neuro Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible to join this trial at the present moment?
"According to the records stored on clinicaltrials.gov, this experiment is actively recruiting participants with its first post being made on October 22nd 2021 and lastly edited January 6th 2023."
Answered by AI
What is the aggregate figure of participants in this clinical experiment?
"Correct. Records published on clinicaltrials.gov reveal that this medical trial, first posted to the site in October of 2021, is actively searching for 100 participants at 1 research centre. The project was last updated on January 6th 2023."
Answered by AI
Share this study with friends
Copy Link
Messenger